Volume 11, Number 1, January 2005

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Edward A. Belongia,* Burney Kieke,* Ruth Lynfield,† Jeffrey P. Davis,‡ and Richard E. Besser§
*Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Wisconsin Division of Public Health, Madison, Wisconsin, USA; and §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Figure 1. A) Actual and predicted fluoroquinolone prescriptions, January 2000 through December 2002. B) Actual and predicted fluoroquinolone prescriptions as a percentage of all outpatient antibiotic prescriptions, January 2000 through December 2002. Tetracycline and related antimicrobial agents were excluded from the denominator in each month. Vertical bars show 95% confidence intervals. All models included categorical effects for year and month and indicator variables for October, November, and December, 2001.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed December 6, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention